Not applicableUnknownNCT03958188What this trial is testingPreOPerative Imaging of NeuroEndocrine TumorsWho this might be right forNeuro-endocrine TumorsSmall Intestine Cancer Hospices Civils de Lyon 47
Early research (Phase 1)Study completedNCT03629756What this trial is testingEvaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesWho this might be right forNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckBreast Cancer+9 more Arcus Biosciences, Inc. 48
Not applicableStudy completedNCT04670445What this trial is testingImproving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerWho this might be right forStage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Early research (Phase 1)WithdrawnNCT06626256What this trial is testingSTIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaWho this might be right forLocally Advanced Cervical CarcinomaLocally Advanced Colorectal CarcinomaLocally Advanced Malignant Solid Neoplasm+24 more City of Hope Medical Center
Early research (Phase 1)Active Not RecruitingNCT05075993What this trial is testingStudy of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsWho this might be right forMetastatic EsophagealGastric CancerMetastatic Head and Neck Carcinoma+5 more M.D. Anderson Cancer Center 352
Very early researchActive Not RecruitingNCT03044977What this trial is testingStudy to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting David Bushnell 20
Not applicableNot Yet RecruitingNCT07689812What this trial is testingRandomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Who this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more Natera, Inc. 920
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Early research (Phase 1)Study completedNCT03000257What this trial is testingBudigalimab (ABBV-181) in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors AbbVie 182
Very early researchUnknownNCT05961111What this trial is testingA Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid TumorsWho this might be right forSarcomaCarcinomaDigestive Cancer+7 more Shanghai Yunying Medical Technology 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291105What this trial is testingPhase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsWho this might be right forMelanomaHead and Neck Squamous Cell CarcinomaColo-rectal Cancer Vyriad, Inc. 87
Early research (Phase 1)Study completedNCT00375245What this trial is testingRapamycin With Grapefruit Juice for Advanced MalignanciesWho this might be right forTumorsNeoplasm Metastasis University of Chicago 41
Not applicableEnded earlyNCT02439008What this trial is testingEarly Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune ResponseWho this might be right forCarcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more Centre Oscar Lambret 28
Early research (Phase 1)Ended earlyNCT04042480What this trial is testingSGN-CD228A in Advanced Solid TumorsWho this might be right forCutaneous MelanomaPleural MesotheliomaHER2 Negative Breast Neoplasms+3 more Seagen Inc. 88
Testing effectiveness (Phase 2)Study completedNCT02611024What this trial is testingPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsWho this might be right forAdvanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more PharmaMar 316
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Looking for participantsNCT05824975What this trial is testingEvaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more GI Innovation, Inc. 358
Early research (Phase 1)Study completedNCT00451880What this trial is testingStudy of XL281 in Adults With Solid TumorsWho this might be right forCancerNon-small-cell Lung CancerColorectal Cancer+2 more Exelixis 180